Crescent Biopharma CBIO
NASDAQ CBIO
$13.92 +0.27 (+1.98%)
At close: Nov 10, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Share-based Compensation (IS) (2025)

Updated

Crescent Biopharma (CBIO) recorded Share-based Compensation (IS) of $1.99 million in Q3 2025, down 62.8% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Share-based Compensation (IS) (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Crescent Biopharma 418.60 Mn -288.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.99 Mn
Jun 30, 2025 5.34 Mn
API Access

Crescent Biopharma Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CBIO&period=max&api_key=YOUR_API_KEY